Icon

VIBATIV (nda022110)- (EQ 250MG BASE/VIAL,EQ 750MG BASE/VIAL)

TELAVANCIN HYDROCHLORIDE CUMBERLAND
EQ 250MG BASE/VIAL,EQ 750MG BASE/VIAL
No No
2027-Jan-01 2014-Sep-11
None None
None No
VIBATIV is a lipoglycopeptide antibacterial drug indicated for the treatment of the following infections in adult patients caused by designated susceptible bacteria: • Complicated skin and skin structure infections (cSSSI) • Hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) caused by susceptible isolates of Staphylococcus aureus. VIBATIV should be reserved for use when alternative treatments are not suitable.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 250MG BASE/VIAL ** ** - - -
EQ 750MG BASE/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.